✦ LIBER ✦

The anti-CD22 monoclonal antibody epratuzumab shows activity in diffuse large-cell NHL

Book ID: 120868263
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2000
Weight: 133 KB
Volume: 1268
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200012680-00016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

B cell therapy with the anti-CD22 monocl

B cell therapy with the anti-CD22 monoclonal antibody epratuzumab: Comment on the editorial by St.Clair and Tedder

✍ David M. Goldenberg; Rhona Stein; John P. Leonard; Serge D. Steinfeld; Thomas Dö 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

Proapoptotic signaling activity of the a

Proapoptotic signaling activity of the anti-CD40 monoclonal antibody dacetuzumab circumvents multiple oncogenic transformation events and chemosensitizes NHL cells

✍ Lewis, T S; McCormick, R S; Stone, I J; Emmerton, K; Mbow, B; Miyamoto, J; Drach 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 898 KB

The HB22.7 Anti-CD22 monoclonal antibody

The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner

✍ Shiloh M Martin; Eric Churchill; Hayes McKnight; Christopher M Mahaffey; Yunpeng 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 294 KB

Anti-CD19 and anti-CD22 monoclonal antib

Anti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell lines

✍ C. Stanciu-Herrera; C. Morgan; L. Herrera 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 691 KB

Experimental treatment of human diffuse

Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab

✍ Franck Assayag; Nicole Brousse; Jérôme Couturier; Elizabeth Macintyre; Claire Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 2 views

Signals involved in T cell activation. T

Signals involved in T cell activation. T cell proliferation induced through the synergistic action of anti-CD28 and anti-CD2 monoclonal antibodies

✍ René A. W. Van Lier; Miranda Brouwer; Lueien A. Aarden 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 654 KB

Monoclonal antibodies (mAb) directed against the T cell differentiation antigen CD28 (Tp44) induce proliferation of resting T lymphocytes in the presence of phorbol esters. Moreover, it has been reported that such antibodies augment and sustain T cell proliferation induced by soluble antigens, phyto